Blueberries reduced blood vessel inflammation in mice, but only with gut microbes present
Blueberries contain compounds linked to cardiovascular health, but what happens when gut bacteria are removed from the equation?…
Mechanical force triggers metabolic changes that promote orthodontic bone formation
Bone adapts to mechanical force through coupled formation and resorption, a principle central to orthodontics. Periodontal ligament (PDL)…
Low vitamin B12 is linked to heart disease. Supplements tell a different story
Low vitamin B12 levels have been linked to cardiovascular disease, prompting researchers to examine how deficiency affects blood…
Beer and liquor show more oral bacteria links than wine in a large US study
From morning coffee and tea to beer, wine, and fruit juice, researchers examined how everyday drinking habits relate…
Cannabis smokers may need more anesthesia during upper endoscopy
Patients who smoke or vape cannabis may need more anesthesia during an upper endoscopy than those who use…
Finnish study finds poor oral health increases jawbone necrosis risks in breast cancer patients
Antiresorptive drugs, which reduce bone breakdown, are an important part of treatment for breast cancer that has spread…
Study identifies Piezo channels as targets for orthodontic care
A new review in Genes & Diseases highlights Piezo channels as important biological links between mechanical forces and…
Consuming fat before carbohydrates reduces post-meal blood glucose
In treating diabetes, post-meal elevation of glucose levels is an important therapeutic target. Existing clinical studies indicate that…
Real-world data reveals higher reported GLP-1 side effects in female patients
The second of a Series of papers presented at the Annual Meeting of The European Association for the…
A chemical used in BPA-free products may have a connection to diabetes control
Researchers measured bisphenol exposure alongside diet and medication adherence in adults with type 2 diabetes, uncovering a more…
Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101
Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies with the…
Early B-cell therapy linked to better MS disease control
For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after…